News - Pharmaceuticals
The human face rewriting Australia’s most common rare disease, cystic fibrosis
New national data from the Australian Cystic Fibrosis Data Registry (ACFDR) has revealed a significant shift in the trajectory of […]
MoreNews - MedTech & Diagnostics
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
The leadership compass is being recalibrated as the old coordinates give way to complexity, contradiction and change. For Liz Carnabuci, […]
MoreNews - Biotechnology
argenx inks new agreement with Australian regenerative medicine biotech
Immunology company argenx has entered into a new strategic partnership agreement with Monash University and Monash-originated spinout Myostellar, to develop […]
MoreDigital & Innovation
Share by Default reforms deliver early gains as medicines phase moves closer
One week after the Share by Default reforms came into force, early data indicates the changes are already delivering significant […]
MoreLeadership & Management
Novartis appoints Anne Harris as new Country President
Novartis Australia & New Zealand has announced the appointment of ex-Pfizer Managing Director Anne Harris as Country President of Australia […]
MoreESG
Healthcare sustainability policies enter ‘uncharted territory’
Sustainability is no longer a future conversation for healthcare. It is a policy, procurement and manufacturing reality. In this Health […]
MoreHuman Resources
AbbVie marks 13 consecutive years as a Great Place to Work
AbbVie Australia has secured Great Place to Work certification for the 13th consecutive year, reinforcing its long-standing reputation for workplace […]
MoreMedical and Science
Australian-first platform cuts medicine research from months to days
A new $2.9 million national project led by Monash University is set to transform the way Australian scientists discover, evaluate […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
August 7, 2026
in News - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
August 7, 2026
in News - MedTech & Diagnostics
argenx inks new agreement with Australian regenerative medicine biotech
August 7, 2026
in News - Biotechnology
The human face rewriting Australia’s most common rare disease, cystic fibrosis
August 7, 2026
in News - Pharmaceuticals
‘We must transcend silos in service of patients,’ says AbbVie VP & GM
August 6, 2026
in News - Pharmaceuticals
The missing 51%: Healthcare’s market failure may be its biggest opportunity
August 6, 2026
in News - MedTech & Diagnostics
Government’s BreastScreen funding contradicts Review, leaving a major reform gap
August 6, 2026
in News - MedTech & Diagnostics
Senate scrutiny underway as states oppose federal policy on health insurance rebate cuts
August 4, 2026
in News - MedTech & Diagnostics
Policy reforms fail as Australia slips to the bottom for health outcomes
August 4, 2026
in News - Pharmaceuticals
Diabetes experts set minimum CGM standards to address controversial media coverage
August 3, 2026
in News - MedTech & Diagnostics
PBS backs first targeted therapy for rare brain cancer in over two decades
August 3, 2026
in News - Pharmaceuticals
Biologics for paediatric Crohn’s PBS listed to address ‘unnecessary suffering’
August 3, 2026
in News - Pharmaceuticals
Telix patent fight over Novartis’ Pluvicto heads toward 2027 trial
August 3, 2026
in News - Pharmaceuticals
First chemo-free combination therapy PBS listed in follicular lymphoma
August 3, 2026
in News - Pharmaceuticals
Gilead’s court clash creates ripple effect in combination drug pricing
July 31, 2026
in News - Pharmaceuticals
Alzheimer’s Centre marks new era but patient access hits construction zone
July 31, 2026
in News - MedTech & Diagnostics
Healthcare sustainability policies enter ‘uncharted territory’
July 31, 2026
in ESG
Rare but not invisible: Push to shift the HTA compass
July 29, 2026
in News - Pharmaceuticals
First integrated kidney centre sets new benchmark
July 29, 2026
in News - MedTech & Diagnostics
Follow Us
Partner with us
News - MedTech & Diagnostics
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
The leadership compass is being recalibrated as the old coordinates give way to complexity, contradiction and change. For Liz Carnabuci, […]
MoreNews - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
The Department of Health has received the final evaluation report into the Prescribed List (PL) reforms from the Nous Group, […]
MoreNews - Biotechnology
argenx inks new agreement with Australian regenerative medicine biotech
Immunology company argenx has entered into a new strategic partnership agreement with Monash University and Monash-originated spinout Myostellar, to develop […]
MoreNews - Pharmaceuticals
The human face rewriting Australia’s most common rare disease, cystic fibrosis
New national data from the Australian Cystic Fibrosis Data Registry (ACFDR) has revealed a significant shift in the trajectory of […]
More